• Search
  • Helpdesk
  • Sales contact

Innovation and Partnerships: The Biotech Perspective

Last updated: November 22, 2024

In the ever-evolving landscape of biotechnology, groundbreaking advancements continue to shape the future of healthcare. In this exclusive interview, Estelle Haenel, Chief Medical Officer at Kayentis, engages in a profound dialogue with Adeline Meilhoc, who leads Clinical Development at ACTICOR Biotech. ACTICOR Biotech is widely recognized for its pioneering work in platelets and GPVI, particularly in the context of ischemic stroke treatment, an emergency care.

Adeline offers a unique perspective, sharing valuable insights into the distinctive needs and challenges that small biotech firms like ACTICOR face when conducting clinical trials. From the intricacies of project-specific demands to the shifting dynamics within the industry, Adeline provides in-depth insights into the complexities and critical service requirements of innovative biotechs.

Download the full interview  👇

Follow us on social media
Subscribe to our newsletter
About the author
Meet us at the following events

SCOPE Europe 2025

OCT 14-15 2025 • Barcelona, Spain
SCOPE Europe | Summit for Clinical Operations Executives | October 14-15, 2025 |Barcelona, Spain

Rethinking Phase 1 Oncology Trials with Electronic Patient-Reported Outcomes

November 4 • 11-12AM EDT / 4-5PM GMT / 5-6PM CET
The primary aim of Phase 1 oncology clinical trials is to determine the safety of a new treatment, and to...